Investors didn't like the medical technology company's fiscal 2025 Q1 update.
AngioDynamics: Fiscal Q1 Earnings Snapshot
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Marex Group plc MRX: This financial services platform provider has seen the Zacks Consensus Estimate for its current year earnings...
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. ARCT: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings...
AngioDynamics: Fiscal Q4 Earnings Snapshot
AngioDynamics: Fiscal Q3 Earnings Snapshot
Stocks that traded heavily or had substantial price changes on Friday: Greenbrier, Constellation Brands rise; AngioDynamics, Agilon Health fall
The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected.
AngioDynamics: Fiscal Q2 Earnings Snapshot
The company didn't get investors excited about its latest set of quarterly figures.